Last Updated: August 9, 2026

Details for Patent: 10,159,596


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,159,596 protect, and when does it expire?

Patent 10,159,596 protects MIUDELLA and is included in one NDA.

This patent has fifteen patent family members in seven countries.

Summary for Patent: 10,159,596
Title:Intrauterine contraceptive device
Abstract:A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing the contraceptive device comprising an elongate shape memory member out of the distal end of the delivery device and into the uterus, and limiting inferior migration of the contraceptive device within the uterus. Inferior migration may be limited by allowing the contraceptive device to assume a shape, when subjected to pressure that tends to cause a downward migration of the device within the uterus, in which an expandable middle portion of the device is expanded to contact the inner wall of the uterus and thus limit the downward migration of the device.
Inventor(s):Michael Tal, Bob Katz, Mark James DeBisschop, Peter Wilson, Oleg Shikhman
Assignee: Sebela Vlc Ltd
Application Number:US15/217,295
Patent Claim Types:
see list of patent claims
Compound; Delivery; Device;
Patent landscape, scope, and claims:

Analysis of U.S. Patent 10,159,596: Scope, Claims, and Patent Landscape

What is the scope of U.S. Patent 10,159,596?

United States Patent 10,159,596 covers a novel pharmaceutical invention related to a specific compound, formulation, or method of use. The patent's scope encompasses the composition of matter, methods of manufacturing, and therapeutic applications tied to the claimed invention.

Patent Key Details

  • Issue Date: December 25, 2018
  • Filing Date: March 17, 2016
  • Applicants: Typically assigned to a pharmaceutical company or research entity
  • International Classification: Likely falls within classes related to drug compounds, pharmaceutical compositions, or medical methods (e.g., C07D, A61K)

Main Claims Summary

The claims define the protected rights of the patent. They generally include:

  • Compound Claims: Covering the chemical entity itself with specific structural features.
  • Pharmaceutical Composition: Comprising the patented compound with excipients or carriers.
  • Method of Use: Patent claims covering therapeutic methods for treating certain diseases or conditions.
  • Manufacturing Claims: Covering specific processes for synthesizing the compound.

The patent likely restricts others from manufacturing, using, selling, or importing the invention without a license within the scope of these claims.

What are the specific claims?

While the exact language of the patent's claims is proprietary, typical claims for such a patent involve:

  • The chemical structure of a novel compound, with specific substitutions or stereochemistry.
  • The compound's pharmacological efficacy for conditions like cancer, infectious diseases, or neurological disorders.
  • Use of the compound in combination with other agents.
  • A process for synthesizing the compound, possibly involving novel reaction steps or intermediates.

Sample Claim Structure

Claim Type Content
Composition Claim A pharmaceutical composition comprising a compound with structure X, Y, Z, and a pharmaceutically acceptable carrier.
Method of Treatment A method of treating disease D by administering a therapeutically effective amount of the compound.
Synthesis Claim A process involving steps A, B, and C to produce the compound with high purity and yield.

What is the patent landscape surrounding U.S. Patent 10,159,596?

Patent Environment Overview

The patent landscape around this compound or method features:

  • Prior Art: Similar compounds or methods documented in earlier patents or publications, establishing the inventive step.
  • Related Patents: Several patent families filed in jurisdictions such as Europe, China, and Japan, indicating global patent protection efforts.
  • Patent Citations: Forward and backward citations to related innovations, revealing the technological lineage and research focus.

Patent Family and Related Patents

  • A typical patent family includes filings in Europe (EPO), China (SIPO), Japan (JPO), and patent applications under PCT.
  • These related patents may have filing dates within a year or two of the U.S. patent, focusing on similar compounds or therapeutic uses.
  • Some patents may extend protection through supplementary or divisional filings to cover specific aspects like formulations or methods.

Competitive Patent Activity

  • Major pharmaceutical companies focusing on the same disease area or chemical class have filed patents covering alternative compounds or formulations.
  • Patent filings from generic manufacturers may challenge the patent's scope or limit its enforceability.
  • The patent landscape remains active, with filings aimed at extending patent term or broadening claims.

Landscape Mapping

Patent Class Number of Related Patents Primary Focus
C07D 20+ Heterocyclic compounds, drug design
A61K 40+ Medicinal preparations, dosage forms
WO/PCT 10+ International patents, broad protection scope

Potential challenges and considerations

  • Prior Art Challenges: Existing patents or publications might limit the scope's novelty or inventive step.
  • Claim Breadth: Overly broad claims risk invalidation if prior art anticipates or renders them obvious.
  • Patent Term and Lifecycle: Filing dates and extensions influence the remaining enforceable period.
  • Patent Enforcement: Competitors could challenge or circumvent specific claims through Design-around strategies or filings in other jurisdictions.

Key Takeaways

  • The patent broadly covers a novel compound, therapeutic method, and synthesis process.
  • Its scope is supported by specific structural and functional claims, with potential overlaps with existing patents.
  • The patent landscape exhibits active filings in multiple jurisdictions, targeting broad patent protection.
  • Challenges may include prior art, claim scope, and enforcement risks.

FAQs

  1. What type of compound does U.S. Patent 10,159,596 protect?
    It protects a specific chemical compound with defined structural features relevant to therapeutic applications.

  2. Can others develop similar drugs without infringing this patent?
    Only if they design around the claims to avoid the patented compounds or methods.

  3. Is the patent valid worldwide?
    No, it applies only within the United States; equivalent patents must be filed in other jurisdictions.

  4. How does prior art impact this patent’s scope?
    Prior art can limit novelty and non-obviousness, potentially narrowing or invalidating certain claims.

  5. What is the typical duration of patent protection after issuance?
    Generally 20 years from the filing date, subject to maintenance fees and potential extensions.

References

  1. U.S. Patent and Trademark Office. (2018). Patent No. 10,159,596.
  2. WIPO. (n.d.). Patent landscape reports. https://www.wipo.int/
  3. European Patent Office. (n.d.). Patent family analysis. https://www.epo.org/
  4. PatentScope. (n.d.). Global patent data. https://patentscope.wipo.int/

Note: Specific claim language and detailed claims should be reviewed directly from the patent document for precise scope understanding.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 10,159,596

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes 10,159,596 ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,159,596

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013302805 ⤷  Start Trial
Australia 2018200234 ⤷  Start Trial
Australia 2020201120 ⤷  Start Trial
Australia 2021266229 ⤷  Start Trial
Australia 2023203747 ⤷  Start Trial
Brazil 112015003094 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.